Investors Alert: Class Action Seeking Recovery Against Neogen

Author: Dylan Bailey Updated: 09-02-2025 08:57 AM

Class Action Filed Against Neogen Corporation

Levi & Korsinsky, LLP is notifying investors regarding a class action securities lawsuit involving Neogen Corporation (NASDAQ: NEOG). This legal action aims to seek recovery for those who have experienced losses related to the company's alleged fraud.

Understanding the Class Definition

This lawsuit is designed for Neogen Corporation investors who may have been adversely impacted by claims of securities fraud. It encompasses activities that occurred between specific dates, creating a focus on ensuring those affected have a platform for potential recovery.

Details of the Case

According to the complaint filed, it is alleged that the defendants issued a series of materially false and misleading statements regarding the integration with the Food Safety Division of the 3M Company. These statements led shareholders to believe that the merger was proceeding smoothly. However, as the integration progressed, it became clear that significant inefficiencies had arisen, which the company did not adequately disclose. Instead, it presented reassurances to investors that it was aware of the issues and was dedicated to resolving them in a timely manner.

Next Steps for Investors

If you have suffered a financial loss in Neogen Corporation during the relevant time period, you can take action by requesting to be appointed as a lead plaintiff. This request must be made by a specified date, although participation in any potential recovery does not necessarily require that you serve in this lead role.

Zero Cost Participation

For individuals who qualify as class members, participation in this class action comes without any upfront costs or fees. This means that you can seek possible compensation without the worry of incurring out-of-pocket legal expenses.

Why Choose Levi & Korsinsky?

With a robust track record built over two decades, Levi & Korsinsky has consistently secured substantial settlements for shareholders involved in complex securities litigations. Their team, comprising over 70 dedicated professionals, is equipped to guide investors through the complexities of securities cases. Recognized by ISS Securities Class Action Services, the firm has repeatedly ranked among the top securities litigation firms in the nation.

Contact Information

For further inquiries or assistance regarding the class action lawsuit, please reach out to:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
Tel: (212) 363-7500
Fax: (212) 363-7171

Frequently Asked Questions

What is the purpose of the class action lawsuit?

The class action lawsuit aims to seek recovery for investors who suffered losses due to alleged securities fraud by Neogen Corporation.

Who can participate in this lawsuit?

Investors of Neogen Corporation who experienced losses during the specified period may be eligible to participate in the lawsuit.

Are there any costs associated with participating?

No, participation in the class action comes without any upfront costs for class members.

What should I do if I want to join the lawsuit?

Interested investors should act quickly to request to be appointed as lead plaintiff before the set deadline.

How can I contact Levi & Korsinsky for more information?

You can reach out to Levi & Korsinsky directly via their office phone number or by visiting their official website for more details.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.